0

Biotech

Biotech Recent News


Galecto's Myelofibrosis Candidate Reduces Bone Marrow Fibrosis
Galecto's Myelofibrosis Candidate Reduces Bone Marrow Fibrosis
Sep 29, 2022, 11:17 AM
Regeneron-Sanofi's Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis
Regeneron-Sanofi's Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis
Sep 29, 2022, 9:54 AM
Idera Pharma Acquires Rare Disease Player, Names New CEO
Idera Pharma Acquires Rare Disease Player, Names New CEO
Sep 29, 2022, 9:52 AM
MorphoSys' Monjuvi Shows Long-Term Durable Response In Blood Cancer Settings
MorphoSys' Monjuvi Shows Long-Term Durable Response In Blood Cancer Settings
Sep 29, 2022, 9:21 AM
Axcella Shares Jump Despite Mixed Bag Data From Mid-Stage NASH Trial
Axcella Shares Jump Despite Mixed Bag Data From Mid-Stage NASH Trial
Sep 29, 2022, 9:17 AM
Kiora Pharma is Starting Human Trials of a Novel Treatment That Could Restore Vision In Patients With Inherited Blindness
Kiora Pharma is Starting Human Trials of a Novel Treatment That Could Restore Vision In Patients With Inherited Blindness
Aligos Co-Founders File Complaint Against Johnson & Johnson Alleging Fraud
Aligos Co-Founders File Complaint Against Johnson & Johnson Alleging Fraud
Sep 29, 2022, 8:40 AM
Windtree Therapeutics Stock Surges After Positive Istaroxime Data In Cardiogenic Shock
Windtree Therapeutics Stock Surges After Positive Istaroxime Data In Cardiogenic Shock
Sep 29, 2022, 7:45 AM
Atara Biotherapeutics to Receive Additional Near-Term Milestone Under Updated Tab-cel Commercialization Pact
Atara Biotherapeutics to Receive Additional Near-Term Milestone Under Updated Tab-cel Commercialization Pact
Sep 29, 2022, 7:30 AM
Merck Inks Supply Deal With Sinopharm To Commercialize COVID-19 Pills In China
Merck Inks Supply Deal With Sinopharm To Commercialize COVID-19 Pills In China
Sep 29, 2022, 7:16 AM
Gilead's Investigation Reveals Two Kingpins Directly Associated With Fake HIV Medications Scheme
Gilead's Investigation Reveals Two Kingpins Directly Associated With Fake HIV Medications Scheme
Sep 29, 2022, 7:10 AM
Medical Implants Could One Day Be Made Of CBD Or Poly Cannabinoids, According To New Study
Medical Implants Could One Day Be Made Of CBD Or Poly Cannabinoids, According To New Study
Sep 28, 2022, 7:57 PM
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
Sep 28, 2022, 4:17 PM
What The Biogen Chart Reveals As Stock Rallies Hard On Alzheimer's Data
What The Biogen Chart Reveals As Stock Rallies Hard On Alzheimer's Data
Sep 28, 2022, 2:53 PM
PepGen's Duchenne Candidate Has Potential For Greater Exon Skipping Capabilities At Lower Doses Versus Sarepta's Candidate, Says Analyst
PepGen's Duchenne Candidate Has Potential For Greater Exon Skipping Capabilities At Lower Doses Versus Sarepta's Candidate, Says Analyst
Sep 28, 2022, 1:59 PM
MaxCyte Inks Platform License With Vertex For Gene-Editing Program For Rare Blood Disorders
MaxCyte Inks Platform License With Vertex For Gene-Editing Program For Rare Blood Disorders
Sep 28, 2022, 12:39 PM
Rallybio's Thrombocytopenia Candidate Shows Rapid, Complete Elimination Of Transfused Platelets
Rallybio's Thrombocytopenia Candidate Shows Rapid, Complete Elimination Of Transfused Platelets
Sep 28, 2022, 12:37 PM
SAB Biotherapeutics Unveils New Data From COVID-19 Programs Reinforcing Efficacy Against Variants
SAB Biotherapeutics Unveils New Data From COVID-19 Programs Reinforcing Efficacy Against Variants
Sep 28, 2022, 12:36 PM
This Analyst Believes Biogen's Lecanemab Data Not 'Slam Dunk' For Complete CMS Approval
This Analyst Believes Biogen's Lecanemab Data Not 'Slam Dunk' For Complete CMS Approval
Sep 28, 2022, 12:30 PM
Aquestive Inks Supply Pact For Its Seizure Treatment Covering European, Middle East Countries
Aquestive Inks Supply Pact For Its Seizure Treatment Covering European, Middle East Countries
Sep 28, 2022, 12:14 PM
KemPharm's Lead Prodrug Shows Favorable Safety Profile For Rare Sleeping Disorder
KemPharm's Lead Prodrug Shows Favorable Safety Profile For Rare Sleeping Disorder
Sep 28, 2022, 12:07 PM
OraSure Secures BARDA Funding For Next-Gen Ebola Diagnostic Test
OraSure Secures BARDA Funding For Next-Gen Ebola Diagnostic Test
Sep 28, 2022, 10:28 AM
ASLAN Pharmaceuticals Presents New Data From Atopic Dermatitis Candidate
ASLAN Pharmaceuticals Presents New Data From Atopic Dermatitis Candidate
Sep 28, 2022, 10:24 AM